Incidental seminal vesicle amyloidosis observed in diagnostic prostate biopsies—are routine investigations for systemic amyloidosis warranted?

Por Yang, Zichu, Laird, Alexander, Monaghan, Ashley, Seywright, Morag, Ahmad, Imran, Leung, Hing Y
Publicado em 2013

Reclassification of the Fuhrman grading system in renal cell carcinoma-does it make a difference?

Por Qayyum, Tahir, McArdle, Peter, Orange, Clare, Seywright, Morag, Horgan, Paul, Oades, Grenville, Aitchison, Michael, Edwards, Joanne
Publicado em 2013

A Prospective Study of the Role of Inflammation in Bladder Cancer

Por Qayyum, Tahir, McArdle, Peter, Hilmy, Mustafa, Going, James, Orange, Clare, Seywright, Morag, Horgan, Paul, Underwood, Mark, Edwards, Joanne
Publicado em 2013

SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis

Por Gao, Meiling, Patel, Rachana, Ahmad, Imran, Fleming, Janis, Edwards, Joanne, McCracken, Stuart, Sahadevan, Kanagasabai, Seywright, Morag, Norman, Jim, Sansom, Owen, Leung, Hing Y
Publicado em 2012

HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer

Por Ahmad, Imran, Patel, Rachana, Singh, Lukram Babloo, Nixon, Colin, Seywright, Morag, Barnetson, Robert J., Brunton, Valerie G., Muller, William J., Edwards, Joanne, Sansom, Owen J., Leung, Hing Y.
Publicado em 2011

Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression

Por Patel, Rachana, Gao, Meiling, Ahmad, Imran, Fleming, Janis, Singh, Lukram B., Rai, Taranjit Singh, McKie, Arthur B., Seywright, Morag, Barnetson, Robert J., Edwards, Joanne, Sansom, Owen J., Leung, Hing Y.
Publicado em 2013